A prospective, cohort study analysing efficacy and tolerability of intravitreal aflibercept monotherapy in patients with Type 1 retinopathy of prematurity
Latest Information Update: 21 Sep 2021
At a glance
- Drugs Aflibercept (Primary)
- Indications Retinopathy of prematurity
- Focus Adverse reactions; Therapeutic Use
- 21 Sep 2021 New trial record